Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Innoviva Inc (INVA)
Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 992,067
  • Shares Outstanding, K 64,087
  • Annual Sales, $ 331,340 K
  • Annual Income, $ 213,920 K
  • 60-Month Beta 0.58
  • Price/Sales 4.77
  • Price/Cash Flow 6.74
  • Price/Book 1.60
Trade INVA with:

Options Overview Details

View History
  • Implied Volatility 55.83% ( +1.43%)
  • Historical Volatility 21.25%
  • IV Percentile 92%
  • IV Rank 58.20%
  • IV High 88.25% on 10/27/23
  • IV Low 10.68% on 10/02/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 2,358
  • Open Int (30-Day) 2,393

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +1,997,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.35 +0.85%
on 02/23/24
16.76 -7.64%
on 01/29/24
-1.19 (-7.14%)
since 01/23/24
3-Month
13.57 +14.08%
on 11/24/23
16.86 -8.21%
on 01/04/24
+1.91 (+14.08%)
since 11/22/23
52-Week
10.64 +45.49%
on 03/10/23
16.86 -8.21%
on 01/04/24
+3.32 (+27.30%)
since 02/23/23

Most Recent Stories

More News
Dominate the Market With 3 Biotech Stocks

The biotech industry’s growth prospects look promising due to considerable investments in research and development (R&D), an innovative drugs pipeline, government initiatives, the growing popularity...

FHTX : 5.98 (-1.81%)
INVA : 15.48 (unch)
VRTX : 430.11 (+0.78%)
3 Lucrative Biotech Stock Buys for Success

The development of orphan medications, innovative biotech equipment, personalized medicine, and strong government support are all contributing to the biotech industry's upward trajectory. Thus, lucrative...

INVA : 15.48 (unch)
ORGO : 3.46 (+2.06%)
VRTX : 430.11 (+0.78%)
Chart of the Day: Innoviva - Individual Investor Favorite

The Chart of the Day belongs to the biopharma company Innoviva (INVA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

INVA : 15.48 (unch)
2024 Buys: Top Biotech Stock Trio to Consider

The biotechnology industry is experiencing significant growth, fueled by rising technological innovations and government support. Therefore, it could be wise to consider fundamentally strong biotech stocks...

EQ : 2.54 (-2.31%)
GNFT : 3.66 (-2.14%)
INVA : 15.48 (unch)
Analyzing the Bullish Opportunities of 3 Biotech Stocks

The biotech industry is well-positioned for solid growth due to rising demand for quality treatments and therapies, a rapidly aging population, adoption of technologies like AI and government initiatives....

INVA : 15.48 (unch)
PBYI : 6.55 (+10.83%)
SGIOY : 11.8800 (+0.08%)
3 Solid Biotech Buys for a Healthy Year-End Portfolio

The growing adoption of AI technologies by biopharmaceutical companies and the increasing government initiatives worldwide are expected to boost the biotech industry. Therefore, it could be wise to buy...

ALNY : 157.65 (-3.17%)
GMAB : 29.16 (+0.17%)
INVA : 15.48 (unch)
3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore,...

ACOR : 13.05 (-3.36%)
CRSP : 83.99 (-2.55%)
INVA : 15.48 (unch)
VRTX : 430.11 (+0.78%)
November Buy Alert: 3 Biotech Stocks Making Gains

Given the breakthrough developments and the rising need to treat chronic diseases, the biotech industry is well-positioned to generate returns. This might make buying biotech stocks like Organogenesis...

AMGN : 289.18 (+1.40%)
INVA : 15.48 (unch)
ORGO : 3.46 (+2.06%)
Innoviva: Q3 Earnings Snapshot

Innoviva: Q3 Earnings Snapshot

INVA : 15.48 (unch)
Innoviva: Q2 Earnings Snapshot

Innoviva: Q2 Earnings Snapshot

INVA : 15.48 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance,...

See More

Key Turning Points

3rd Resistance Point 15.92
2nd Resistance Point 15.78
1st Resistance Point 15.63
Last Price 15.48
1st Support Level 15.34
2nd Support Level 15.20
3rd Support Level 15.05

See More

52-Week High 16.86
Last Price 15.48
Fibonacci 61.8% 14.49
Fibonacci 50% 13.75
Fibonacci 38.2% 13.02
52-Week Low 10.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar